They analyzed the expression of two previously unknown PC genes, PCT19 and CEACAM21, and found that aggressive CRPC is associated with the G allele rs11672691, which is involved in regulation of PCT19 and CEACAM21 gene expression and affects the cellular properties of the prostate tumor. This evidence concerns the gene CEACAM21 and pachyonychia congenita.